wbldb
home
|
authors
|
theses
Khosla, Sundeep
1
;
Shane, Elizabeth
2
A crisis in the treatment of osteoporosis
J Bone Miner Res
. August 2016;31(8):1485-1487
©2016 American Society for Bone and Mineral Research
Affiliations
1
Robert and Arlene Kogod Center on Aging and Endocrine Research Unit, Mayo Clinic College of Medicine, Rochester, MN, USA
2
Division of Endocrinology, Department of Medicine,
Columbia University
, New York, NY, USA
Links
DOI:
10.1002/jbmr.2888
PubMed:
27335158
WoS:
000383717200001
History
Received: 2016-06-15
Revised: 2016-06-16
Accepted: 2016-06-17
Online: 2016-06-28
Cited Works (4)
Year
Entry
2015
Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996–2012: an ecological analysis.
J Bone Miner Res
. December 2015;30(12):2179-2187.
2011
Russell RGG. Bisphosphonates: the first 40 years.
Bone
. July 2011;49(1):2-19.
2016
Black DM, Rosen CJ. Postmenopausal osteoporosis.
NEJM
. January 21, 2016;374(3):254-262.
2012
Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A, Mitchell PJ, Silverman S, Singleton R, Siris E; ASBMR Task Force on Secondary Fracture Prevention. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention.
J Bone Miner Res
. October 2012;27(10):2039-2046.
Cited By (29)
Year
Entry
2018
Trajanoska K, Morris JA, Oei L, Zheng H-F, Evans DM, Kiel DP, Ohlsson C, Richards JB, Rivadeneira F; GEFOS/GENOMOS consortium; 23andMe research team. Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.
BMJ
. August 29, 2018;362:k3225.
2020
Nguyen HH, Lakhani A, Shore-Lorenti C, Zebaze R, Vincent AJ, Milat F, Ebeling PR. Asian ethnicity is associated with atypical femur fractures in an Australian population study.
Bone
. June 2020;135:115319.
2020
Demirtas A, Rajapakse CS, Ural A. Assessment of the multifactorial causes of atypical femoral fractures using a novel multiscale finite element approach.
Bone
. June 2020;135:115318.
2021
Androjna C, Yee CS, White CR, Waldorff EI, Ryaby JT, Zborowski M, Alliston T, Midura RJ. A comparison of alendronate to varying magnitude PEMF in mitigating bone loss and altering bone remodeling in skeletally mature osteoporotic rats.
Bone
. February 2021;143:115761.
2021
Soundia A, Hadaya D, Chau Y, Gkouveris I, Bezouglaia O, Dry S, Pirih F, Aghaloo T, Tetradis S. Local RANKL delivery improves socket healing in bisphosphonate treated rats.
Bone
. July 2021;148:115945.
2022
Revel M, Bermond F, Duboeuf F, Mitton D, Follet H. Influence of loading conditions in finite element analysis assessed by HR–pQCT on ex vivo fracture prediction.
Bone
. January 2022;154:116206.
2024
Liu Y, Arora T, Zhang J, Sodhi SK, Xie F, Curtis JR. The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare.
Bone
. January 2024;178:116954.
2017
Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E. Addressing the crisis in the treatment of osteoporosis: a path forward.
J Bone Miner Res
. March 2017;32(3):424-430.
2020
Conley RB, Adib G, Adler RA, Åkesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman‐Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kužma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel DP. Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition.
J Bone Miner Res
. January 2020;35(1):36-52.
2020
Schepper JD, Collins F, Rios‐Arce ND, Kang HJ, Schaefer L, Gardinier JD, Raghuvanshi R, Quinn RA, Britton R, Parameswaran N, McCabe LR. Involvement of the gut microbiota and barrier function in glucocorticoid‐induced osteoporosis.
J Bone Miner Res
. April 2020;35(4):801-820.
2022
Whittier DE, Samelson EJ, Hannan MT, Burt LA, Hanley DA, Biver E, Szulc P, Sornay-Rendu E, Merle B, Chapurlat R, Lespessailles E, Wong AKO, Goltzman D, Khosla S, Ferrari S, Bouxsein ML, Kiel DP, Boyd SK. Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk.
J Bone Miner Res
. March 2022;37(3):428-439.
2022
Chandran M, Ebeling PR, Mitchell PJ, Nguyen TV; Executive Committee of the Asia Pacific Consortium on Osteoporosis (APCO). Harmonization of osteoporosis guidelines: paving the way for disrupting the status quo in osteoporosis management in the Asia Pacific.
J Bone Miner Res
. April 2022;37(4):608-615.
2022
Ralston KAP, Hauser B, Paskins Z, Ralston SH. Effective communication and the osteoporosis care gap.
J Bone Miner Res
. November 2022;37(11):2049-2054.
2023
Haider IT, Loundagin LL, Sawatsky A, Kostenuik PJ, Boyd SK, Edwards WB. Twelve months of denosumab and/or alendronate is associated with improved bone fatigue life, microarchitecture, and density in ovariectomized cynomolgus monkeys.
J Bone Miner Res
. March 2023;38(3):403-413.
2023
Zhou W, van Rooij JGJ, van de Laarschot DM, Zervou Z, Bruggenwirth H, Appelman-Dijkstra NM, Ebeling PR, Demirdas S, Verkerk AJMH, Zillikens MC. Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients.
J Bone Miner Res
. June 2023;38(6):896-906.
2023
Ebeling PR. Hip fractures and aging: a global problem requiring coordinated global solutions.
J Bone Miner Res
. August 2023;38(8):1062-1063.
2019
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab
. May 2019;104(5):1595-1622.
2019
Compston JE, McClung MR, Leslie WD. Osteoporosis.
Lancet
. January 26, 2019;393(10169):364-376.
2017
Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges.
Lancet Diabetes Endocrinol
. November 2017;5(11):898-907.
2019
Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, Liu C-T, Lorentzon M, Mellstrom D, Merle B, Nethander M, Rizzoli R, Sornay-Rendu E, Van Rietbergen B, Sundh D, Wong AKO, Ohlsson C, Demissie S, Kiel DP, Bouxsein ML. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study.
Lancet Diabetes Endocrinol
. January 2019;7(1):34-43.
2020
Lewiecki EM, Chastek B, Sundquist K, Williams SA, Weiss RJ, Wang Y, Fitzpatrick LA, Curtis JR. Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017.
Osteoporos Int
. July 2020;31(7):1299-1304.
2020
Paskins Z, Torres Roldan VD, Hawarden AW, Bullock L, Meritxell Urtecho S, Torres GF, Morera L, Espinoza Suarez NR, Worrall A, Blackburn S, Chapman S, Jinks C, Brito JP. Quality and effectiveness of osteoporosis treatment decision aids: a systematic review and environmental scan.
Osteoporos Int
. October 2020;31(10):1837-1851.
2020
Lewiecki EM, Wright NC, Singer AJ. Racial disparities, FRAX, and the care of patients with osteoporosis.
Osteoporos Int
. November 2020;31(11):2069-2071.
2020
Lewiecki EM, Binkley N, Clark P, Kim S, Leslie WD, Morin SN. Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico.
Osteoporos Int
. November 2020;31(11):2073-2076.
2021
Johannesdottir F, Allaire B, Kopperdahl DL, Keaveny TM, Sigurdsson S, Bredella MA, Anderson DE, Samelson EJ, Kiel DP, Gudnason VG, Bouxsein ML. Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location.
Osteoporos Int
. February 2021;32(2):261-269.
2017
Lloyd AA, Gludovatz B, Riedel C, Luengo EA, Saiyed R, Marty E, Lorich DG, Lane JM, Ritchie RO, Busse B, Donnelly E. Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance.
Proc Natl Acad Sci USA
. August 15, 2017;114(33):8722-8727.
2022
Ng CATT.
Getting the Jump on Healthy Bones: The Skeletal Effects of Impact Physical Activity Across the Lifespan
[PhD thesis]. Monash University; 2022.
2021
Whittier DEW.
The Assessment of Fragility Fracture Risk Using HR-PQCT as a Novel Tool for Diagnosis of Osteoporosis
[PhD thesis]. Calgary, AB: University of Calgary; August 2021.
2019
Demirtas A.
Assessment of the Influence of Possible Side Effects of Long-Term Bisphosphonate Treatment on Cortical Bone Fracture Resistance Using Finite Element Modeling
[PhD thesis]. Villanova, PA: Villanova University; July 2019.